Annika Kim Constantino, CNBC, June 20, 2023 The U.S. Food and Drug Administration’s Covid strain selection for the next round of shots puts Pfizer, Moderna and Novavax on track to deliver new jabs in time for the fall — a decisive win for the vaccine makers as they …
FDA authorizes Pfizer’s COVID omicron booster as fourth shot for kids under 5
Annika Kim Constantino, CNBC, March 14, 2023 The U.S. Food and Drug Administration on Tuesday authorized Pfizer’s omicron booster shot for kids under five years old who were previously vaccinated with three doses of the company’s original vaccine. Children six months through four …
U.S. plans to stop buying COVID shots for the public this fall. Here’s what that means for you
Spencer Kimball, CNBC, February 6, 2023 The U.S. will stop buying Covid shots at a reduced price for the entire country and shift vaccine distribution to the private market as soon as early fall, shifting the cost to U.S. insurers …
XBB.1.5 omicron subvariant is the most transmissible version of COVID yet, WHO says
Spencer Kimball, CNBC, January 4, 2023 The XBB.1.5 omicron subvariant that’s currently dominating the U.S. is the most contagious version of Covid-19 yet, but it doesn’t appear to make people sicker, according to the World Health Organization. Maria Van Kerkhove, …
COVID and flu hospitalizations increase as holidays approach, while RSV retreats in some states
Spencer Kimball, CNBC, December 9, 2022 Covid and flu hospitalizations are increasing, while respiratory syncytial virus appears to be retreating in some states, the Centers for Disease Control and Prevention reported Friday. As millions of people prepare to travel and …